Islam H Mohamed , MD (@islamhassanm) 's Twitter Profile
Islam H Mohamed , MD

@islamhassanm

GI fellow @mizzou 🐯 | @UMKC IM 🦘 | GHHS 2024 🥇| @cairouniv MD 🇪🇬| Sky is the limit 💯 🇪🇬🇦🇪🇺🇸

ID: 220392927

linkhttps://scholar.google.com/citations?hl=en&user=WbyifUkAAAAJ calendar_today27-11-2010 17:08:44

14,14K Tweet

2,2K Takipçi

536 Takip Edilen

Nadeem Yousaf (@nadeemyousafmd) 's Twitter Profile Photo

Excited to share our meta-analysis of RCTs which hopefully impact on nutrition guidelines 👉🏼When to feed after percutaneous endoscopic gastrostom 📚aspenjournals.onlinelibrary.wiley.com/doi/10.1002/nc… ACG ASGE GI Endoscopy American Gastroenterological Association (AGA) #GITwitter American Society for Nutrition American Society for Nutrition Journals Nutrition.gov

Yazan Abboud, M.D. (@yazanabboudmd) 's Twitter Profile Photo

After years of work, challenges, and dreams, I finally submitted my application for #GIFellowship Extremely thankful for the support of my mentors at Cedars-Sinai Academic Medicine Rutgers Internal Medicine Residency Rutgers University Excited for the interview season and the upcoming journey💫 AAMC ID: 15137852 #GiTwitter

After years of work, challenges, and dreams, I finally submitted my application for #GIFellowship

Extremely thankful for the support of my mentors at <a href="/CedarsSinaiMed/">Cedars-Sinai Academic Medicine</a> <a href="/RutgersIMRes/">Rutgers Internal Medicine Residency</a> <a href="/RutgersU/">Rutgers University</a>
Excited for the interview season and the upcoming journey💫

AAMC ID: 15137852
#GiTwitter
Islam H Mohamed , MD (@islamhassanm) 's Twitter Profile Photo

Watch out for this ⭐️ during this GI fellowship match. Any program would be lucky to have a strong clinician & researcher and most of all a 💎 of a human being! Best of luck Hazem Abosheaishaa,MD,MSc!

Ahmed Abdelwahed, MD (@ahmedawahedmd) 's Twitter Profile Photo

10 years ago, I made the decision to pursue a career in gastroenterology. Now, I’m closer than ever to make it happen. This wouldn’t have happened without the support of everyone who had my back throughout this long journey. The story continues! #GIMatch2025 #GITwitter #Match2025

10 years ago, I made the decision to pursue a career in gastroenterology. Now, I’m closer than ever to make it happen. This wouldn’t have happened without the support of everyone who had my back throughout this long journey. The story continues! #GIMatch2025 #GITwitter #Match2025
Hazem Abosheaishaa,MD,MSc (@hazemabosheaish) 's Twitter Profile Photo

Publication Alert 🔔 🔥🔥🔥 Our meta analysis about using Hemospray for tumor-related GI bleeding in the European Journal of Gastroenterology and Hepatology (EJGH) by our team GI Research Club Islam H Mohamed , MD Omar T Ahmed Khaled Elfert Monzer Abdalla, MD Abdallfatah Ahmed Hemospray achieved

UF Gastroenterology & Hepatology (@ufhepgastro) 's Twitter Profile Photo

New GI Fellow Spotlight 🌟 Ahmed Al Qady Ahmed Al Qady (Salih) 🔥🐊 -Hometown: Sudan -Med school: Cairo University, Egypt -Residency: Indiana University-Muncie -Career interests: MedEd, pancreatology -Hobbies: culinary exploring, Arabic poetry and mobile photography

New GI Fellow Spotlight 🌟

Ahmed Al Qady <a href="/Ahmed_salih_md/">Ahmed Al Qady (Salih)</a> 🔥🐊

-Hometown: Sudan
-Med school: Cairo University, Egypt
-Residency: Indiana University-Muncie 
-Career interests: MedEd, pancreatology
-Hobbies: culinary exploring, Arabic poetry and mobile photography
Hazem Abosheaishaa,MD,MSc (@hazemabosheaish) 's Twitter Profile Photo

Publication Alert 🔔 Our latest publication by the team GI Research Club is now online 🔥🔥🔥 “Efficacy, safety, and impact on procedural outcomes of local anesthesia in endoscopic submucosal dissection: a systematic review and meta-analysis” ✅ Using Local anaesthetics in

Islam H Mohamed , MD (@islamhassanm) 's Twitter Profile Photo

🎉 Thrilled to have multiple acceptances in AASLD and ACG conferences !💩 📚 40+ abstracts, 10 as first author 🤝 Excited to connect with colleagues and mentors in my first conference as a GI fellow🤓📚 #AASLD2024 #ACG2024

🎉 Thrilled to have multiple acceptances in AASLD and ACG conferences !💩 

📚 40+ abstracts, 10 as first author

🤝 Excited to connect with colleagues and mentors in my first conference as a GI fellow🤓📚

#AASLD2024 #ACG2024
Hazem Abosheaishaa,MD,MSc (@hazemabosheaish) 's Twitter Profile Photo

New publication by the team GI Research Club 👉 Accepted without revisions 🔥🔥🔥 “The Egyptian journey from having the highest prevalence of hepatitis C virus to being the first to achieve “gold tier” in conquering the disease” ✅ Our review reveals the approach and the

Islam H Mohamed , MD (@islamhassanm) 's Twitter Profile Photo

So excited to share the Egyptian 🇪🇬 journey towards eliminating endemic Hep C! This journey started with all of us—physicians, healthcare workers, and the government. So proud to have my name on a manuscript close to my heart ❤️ Congrats Hazem Abosheaishaa,MD,MSc on another one ☝🏼🎉

So excited to share the Egyptian 🇪🇬 journey towards eliminating endemic Hep C! This journey started with all of us—physicians, healthcare workers, and the government. So proud to have my name on a manuscript close to my heart ❤️ Congrats <a href="/HazemAbosheaish/">Hazem Abosheaishaa,MD,MSc</a> on another one ☝🏼🎉
Islam H Mohamed , MD (@islamhassanm) 's Twitter Profile Photo

Choosing GI is the best decision I’ve ever made 🙏🏻 🔬 Wide spectrum of procedures 🩺 Medically complex IBD & liver patients 🏥 Inpatient and outpatient care To all the future gastro lovers in the #GIMatch, it’s worth it! Best of luck 🍀 and may your dreams come true ✨

Fouad Jaber, MD, MS (@fouadsjaber) 's Twitter Profile Photo

🚨New Publication 🚨 Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review Ad Meta-Analysis of Randomized Controlled Trials ⚡️In 5 trials involving 1120 patients with moderate to severe UC, targeting IL-23 showed:

🚨New Publication 🚨

Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review Ad Meta-Analysis of Randomized Controlled Trials

⚡️In 5 trials involving 1120 patients with moderate to severe UC, targeting IL-23 showed: